BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 17, 2020
View Archived Issues
Innovent initiates phase I/II studies of IBI-318
Read More
Blood cells. Lots of them
Read More
FDA accepts IND application for phase Ia study of PRA-023
Read More
First participant dosed in phase I study of TBAJ-587
Read More
Sichuan Haisco Pharmaceutical patents CRBN-comprising PROTACs
Read More
Galapagos discloses new SIK inhibitors
Read More
Shanghai Zhimeng Biopharma presents new KCNQ2 activators
Read More
KEAP1/NRF2 interaction inhibitors presented by Ube Industries
Read More
Positive final data presented from COMBAT/KEYNOTE-202 triple combination study in PDAC
Read More
GenScript discloses new CD47 and PD-L1-targeting proteins
Read More
Evaluation of the modafinil analogue (S,S)-CE-158 in neurochemical and behavioral studies in rats
Read More
Cerecor initiates dosing in phase Ib study of CERC-007 in relapsed/refractory multiple myeloma
Read More
NP + GPC DNA vaccine candidate protects cynomolgus macaques from Crimean-Congo hemorrhagic fever
Read More
Topline data from phase II study of vocacapsaicin in total knee arthroplasty surgery
Read More
Researchers develop a mitometin-testing murine model of ALS
Read More
First subjects dosed in phase I study of PN-235
Read More
Abpro initiates phase II/III registrational studies of ABP-300 as treatment of COVID-19
Read More
FDA places partial clinical hold on odronextamab lymphoma trials
Read More
Phase I data presented for cannabidivarin for treating epilepsy in patients with Rett syndrome
Read More
Through mTOR, ketamine affects protein translation hub
Read More
FDA approves Margenza for pretreated metastatic HER2-positive breast cancer
Read More
New phase III trial evaluates siltuximab for COVID-19 or viral-associated ARDS
Read More
Molecular Partners advances pipeline
Read More
Heat Biologics completes ZVX-60 gp96-based COVID-19 vaccine cell line
Read More
Interim phase II data for darolutamide demonstrate efficacy in advanced AR-positive TNBC
Read More